![](/img/cover-not-exists.png)
ASP2215 in the treatment of relapsed/refractory acute myeloid leukemia with FLT3 mutation: background and design of the ADMIRAL trial
Gorcea, Claudia M, Burthem, John, Tholouli, EleniLanguage:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2017-0582
Date:
March, 2018
File:
PDF, 1.23 MB
english, 2018